MULTIPRONGED COTARGETING OF ALK/ROS1 AND COMPENSATORY FOCAL ADHESION KINASES IN LUNG CANCER AS A PREEMPTIVE STRIKE TO PREVENT DEVELOPMENT OF DRUG RESISTANCE.
$576,450FY2022Defense Health AgencyDOD
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.